Multiple sclerosis (MS) is diagnosed through a combination of neurological exams, MRI scans, and sometimes spinal fluid analysis, all guided by a formal set of rules called the McDonald criteria. There is no single test that confirms MS on its own. Instead, doctors piece together evidence showing that the immune system has attacked the protective coating around nerves in at least two different areas of the central nervous system, at two different points in time. Getting to a diagnosis often takes multiple visits and tests, because MS symptoms overlap with many other conditions.
Why MS Is Hard to Diagnose Quickly
Early MS symptoms like numbness, blurred vision, fatigue, or tingling can look identical to dozens of other conditions. Your primary care doctor may initially investigate vitamin deficiencies, infections, or stress before MS becomes a serious consideration. If your symptoms persist or worsen, you’ll typically be referred to a neurologist who specializes in the brain and spinal cord.
The diagnostic process can feel frustratingly slow. You may need several rounds of testing over weeks or months. This is partly because the formal diagnostic criteria require evidence that nerve damage has occurred in more than one location and at more than one time, which sometimes means waiting for new symptoms or new findings on a follow-up scan.
The McDonald Criteria
The McDonald criteria are the internationally accepted rules neurologists use to diagnose MS. They were substantially revised in 2024 to reflect advances in imaging and biomarkers. The core principle has stayed the same: a diagnosis requires proof of two things.
The first is called dissemination in space, meaning the immune system has caused damage in at least two separate areas of the central nervous system. The qualifying locations include the area around the brain’s fluid-filled ventricles (periventricular), regions near or within the brain’s outer layer (juxtacortical or intracortical), the brainstem and cerebellum (infratentorial), and the spinal cord. Under the 2024 revision, the optic nerve now counts as a fifth qualifying location, which is a meaningful change since vision problems are one of the most common early MS symptoms.
The second requirement is dissemination in time, meaning damage has occurred on more than one occasion. This can be shown by a second clinical episode, new lesions appearing on a follow-up MRI, or certain patterns on an initial MRI that indicate both old and new activity happening simultaneously.
The 2024 criteria also allow newer MRI markers to support a diagnosis in specific situations. These include the central vein sign (a tiny vein visible in the center of a brain lesion, which is characteristic of MS) and paramagnetic rim lesions (lesions with a distinctive border that suggests ongoing, smoldering inflammation). The updated criteria also now apply across the full lifespan, from children to adults over 50, using a unified framework rather than separate rules for different age groups.
What Happens During an MRI
MRI is the most important tool in MS diagnosis. It produces detailed images of the brain and spinal cord that can reveal areas where the nerve coating (myelin) has been damaged. These damaged areas show up as bright spots called lesions.
Neurologists look for specific patterns. Lesions that sit right next to the brain’s ventricles are a hallmark of MS. A classic finding is “Dawson fingers,” which are oval-shaped lesions that radiate outward from the ventricles, following the small veins that run perpendicular to them. Lesions touching the brain’s outer cortex are also highly specific to MS and help distinguish it from other conditions that cause similar-looking white spots.
Spinal cord lesions in MS have their own typical signature: they tend to be relatively small, located toward the edges of the cord, most common in the cervical (neck) region, and shorter than two vertebral segments in length. A spinal cord lesion combined with a lesion in the brainstem or cerebellum is strongly suggestive of MS.
You’ll often receive a contrast dye through an IV during the MRI. Lesions that light up with contrast are actively inflamed, while those that don’t are older. Seeing both types on a single scan can satisfy the “dissemination in time” requirement, potentially speeding up diagnosis.
Spinal Fluid Analysis
A lumbar puncture (spinal tap) collects a small sample of cerebrospinal fluid from your lower back. The lab checks for oligoclonal bands, which are proteins produced by an overactive immune response within the central nervous system. Their presence supports an MS diagnosis but does not confirm it on its own.
Under the 2024 McDonald criteria, another spinal fluid marker, kappa free light chains, can also be used as supporting evidence. This test measures a specific type of antibody fragment and may be easier for some labs to process. Spinal fluid analysis is particularly useful when MRI findings are borderline or when the neurologist needs extra confidence before making a diagnosis.
Visual Evoked Potential Testing
This test measures how quickly electrical signals travel along the nerve pathway from your eyes to the visual processing area of your brain. You sit in front of a screen displaying a flashing checkerboard pattern while electrodes on your scalp record the brain’s response. The test is painless and takes about 30 to 45 minutes.
In MS, the myelin damage slows these signals down, even if you haven’t noticed any vision problems. That makes evoked potential testing valuable for detecting “subclinical” damage, nerve injury that exists but hasn’t produced obvious symptoms yet. Optic neuritis (inflammation of the optic nerve) is the most common reason neurologists order this test, and it remains one of the earliest and most recognizable presentations of MS.
Blood Tests and Ruling Out Other Conditions
No blood test can diagnose MS, but blood work plays a critical role in excluding conditions that mimic it. The list of MS mimics is long, and missing one of them can lead to a wrong diagnosis and the wrong treatment.
Common conditions that can look like MS include lupus, sarcoidosis, Lyme disease, antiphospholipid syndrome, and vitamin B12 deficiency. Each of these can cause inflammation or damage in the brain and spinal cord that produces MS-like lesions on MRI and MS-like symptoms in daily life.
Two conditions deserve special attention. Neuromyelitis optica spectrum disorder (NMOSD) and MOG-associated disorder (MOGAD) both cause attacks on the central nervous system that closely resemble MS, but they require different treatments. Blood tests for specific antibodies (aquaporin-4 for NMOSD, MOG antibodies for MOGAD) can distinguish them. These tests are especially important for people of Asian or African American ethnicity, where NMOSD and MOGAD are more common relative to MS.
Diagnosing MS in Children
MS can occur in children, though it’s far less common than in adults. The same McDonald criteria now apply across all ages, but there are important caveats. Young children who present with a condition called acute disseminated encephalomyelitis (ADEM), a widespread brain inflammation that can look very similar to MS on MRI, need to be evaluated differently. In ADEM, multiple lesions and mixed old-and-new inflammation are expected features of the single episode, not evidence of two separate events. For a child with ADEM to receive an MS diagnosis, they need a second, clearly separate attack that doesn’t fit the ADEM pattern.
MOG antibodies are detected in 18 to 35 percent of children with a first episode of inflammatory brain or nerve damage, and their presence generally predicts a non-MS disease course. Fewer than 25 percent of children who do have MS test positive for MOG antibodies. When a child has a first episode of neurological symptoms, neurologists typically recommend a follow-up MRI at three months to check for new lesions, which is an efficient window for catching early MS without delaying treatment.
What a Diagnosis Looks Like in Practice
The typical path starts with your primary care doctor ordering basic blood work and possibly referring you to a neurologist. The neurologist performs a detailed neurological exam, checking reflexes, coordination, eye movements, sensation, and strength. If MS is suspected, brain and spinal cord MRI scans come next, often with and without contrast dye. Depending on the findings, a lumbar puncture, evoked potential testing, or additional blood work may follow.
If the MRI shows lesions in the right locations with evidence of activity at different times, and blood tests have excluded other causes, the diagnosis can sometimes be made within a few weeks. In other cases, the initial findings are suggestive but not conclusive, and the neurologist will schedule follow-up MRIs in three to six months to watch for new lesions. Some people spend months in a gray area where MS is suspected but not yet confirmed. The 2024 criteria revisions were designed in part to shorten this waiting period by accepting a broader range of evidence, including the new MRI markers and the addition of the optic nerve as a qualifying location.
In certain situations, people with no neurological symptoms at all receive an MS diagnosis. This can happen when an MRI performed for an unrelated reason (a head injury, migraines) incidentally reveals lesions with MS-typical patterns. Under the updated criteria, this “radiologically isolated syndrome” can now meet the threshold for an MS diagnosis in specific circumstances, allowing earlier treatment before symptoms develop.